These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
3. Should women with atypical squamous cells, cannot exclude high-grade squamous intraepithelial lesion, receive reflex human papillomavirus-DNA testing? Liman AK, Giampoli EJ, Bonfiglio TA. Cancer; 2005 Dec 25; 105(6):457-60. PubMed ID: 16104044 [Abstract] [Full Text] [Related]
4. Atypical squamous cells-cannot exclude high-grade squamous intraepithelial lesion (ASC-H): a result not to be ignored. Barreth D, Schepansky A, Capstick V, Johnson G, Steed H, Faught W. J Obstet Gynaecol Can; 2006 Dec 25; 28(12):1095-1098. PubMed ID: 17169233 [Abstract] [Full Text] [Related]
5. Liquid-based cytology--new possibilities in the diagnosis of cervical lesions. Juric D, Mahovlić V, Rajhvajn S, Ovanin-Rakić A, Skopljanac-Macina L, Barisić A, Projić IS, Babić D, Susa M, Corusić A, Oresković S. Coll Antropol; 2010 Mar 25; 34(1):19-24. PubMed ID: 20432728 [Abstract] [Full Text] [Related]
7. Cytologic features of low-grade squamous intraepithelial lesion in thinprep papanicolaou test slides and conventional smears: comparison of cases that performed poorly with those that performed well in the College of American Pathologists Interlaboratory Comparison Program in Cervicovaginal Cytology. Renshaw AA, Dubray-Benstein B, Haja J, Hughes JH, Cytopathology Resource Committee, College of American Pathologists. Arch Pathol Lab Med; 2005 Jan 25; 129(1):23-5. PubMed ID: 15628904 [Abstract] [Full Text] [Related]
8. The significance of "low-grade squamous intraepithelial lesion, cannot exclude high-grade squamous intraepithelial lesion" as a distinct squamous abnormality category in Papanicolaou tests. Elsheikh TM, Kirkpatrick JL, Wu HH. Cancer; 2006 Oct 25; 108(5):277-81. PubMed ID: 16937376 [Abstract] [Full Text] [Related]
9. Split-sample analysis of discarded cells from liquid-based Pap smear sampling devices. Rinas AC, Mittman BW, Le LV, Hartmann K, Cayless J, Singh HK. Acta Cytol; 2006 Oct 25; 50(1):55-62. PubMed ID: 16514841 [Abstract] [Full Text] [Related]
11. Does liquid-based technology really improve detection of cervical neoplasia? A prospective, randomized trial comparing the ThinPrep Pap Test with the conventional Pap Test, including follow-up of HSIL cases. Obwegeser JH, Brack S. Acta Cytol; 2001 Oct 25; 45(5):709-14. PubMed ID: 11575648 [Abstract] [Full Text] [Related]
12. Implementation of the ThinPrep Imaging System in a tertiary military medical center. Duby JM, DiFurio MJ. Cancer; 2009 Aug 25; 117(4):264-70. PubMed ID: 19536887 [Abstract] [Full Text] [Related]
14. Comparison of the clinical significance of the Papanicolaou test interpretations LSIL cannot rule out HSIL and ASC-H. Difurio MJ, Mailhiot T, Sundborg MJ, Nauschuetz KK. Diagn Cytopathol; 2010 May 25; 38(5):313-7. PubMed ID: 19813258 [Abstract] [Full Text] [Related]
15. Comparison of fluid-based, thin-layer processing and conventional Papanicolaou methods for uterine cervical cytology. Wang TY, Chen HS, Yang YC, Tsou MC. J Formos Med Assoc; 1999 Jul 25; 98(7):500-5. PubMed ID: 10463000 [Abstract] [Full Text] [Related]
16. Liquid-based cervical cytologic smear study and conventional Papanicolaou smears: a metaanalysis of prospective studies comparing cytologic diagnosis and sample adequacy. Bernstein SJ, Sanchez-Ramos L, Ndubisi B. Am J Obstet Gynecol; 2001 Aug 25; 185(2):308-17. PubMed ID: 11518884 [Abstract] [Full Text] [Related]
18. Oral contraceptive pills are associated with artifacts in ThinPrep Pap smears that mimic low-grade squamous intraepithelial lesions. Morrison C, Prokorym P, Piquero C, Wakely PE, Nuovo GJ. Cancer; 2003 Apr 25; 99(2):75-82. PubMed ID: 12704686 [Abstract] [Full Text] [Related]
19. Performance of a fluid-based, thin-layer papanicolaou smear method in the clinical setting of an independent laboratory and an outpatient screening population in New England. Díaz-Rosario LA, Kabawat SE. Arch Pathol Lab Med; 1999 Sep 25; 123(9):817-21. PubMed ID: 10458830 [Abstract] [Full Text] [Related]
20. Adjunctive human papillomavirus DNA testing is a useful option in some clinical settings for disease risk assessment and triage of females with ASC-H Papanicolaou test results. Bandyopadhyay S, Austin RM, Dabbs D, Zhao C. Arch Pathol Lab Med; 2008 Dec 25; 132(12):1874-81. PubMed ID: 19061283 [Abstract] [Full Text] [Related] Page: [Next] [New Search]